Navigation Links
British Scientists Doubt Delhi Doctor’s Stem Cell Claim

A Delhi-based doctor’s claim of having produced and purified stem cells from human embryos to treat incurable diseases does not have many takers in the British medical fraternity.

The Guardian reported Friday that experts here have called // on Indian authorities to impose tighter curbs on clinics in India that make extravagant claims about the use of embryonic stem cells.

The doctor whose claims have evoked some concern here is Geeta Shroff, who, in the early 90s had hit the headlines by reportedly developing a technique for determining a baby's sex while in the womb without taking a scan.

Shroff, who runs a genetic research facility and hospital in south Delhi, now claims to have treated over 100 terminally ill patients with stem cell therapy.

Shroff told the newspaper: 'My patients often have no other choice. I am their last chance.' The report quoted some patients who claimed improvement in their medical conditions.

According to Stephen Minger, director of the King's College London's stem cell biology laboratory: 'It is highly implausible and frankly downright dangerous. If the Indian government wants to promote stem cell research, it needs to seriously look at regulation of these doctors and if necessary close them down.'

An editorial in the British Medical Journal this year warned that Indian authorities needed to act to 'prevent the escalating numbers of clinics offering stem cell cures for all sorts of ills'.

Minger told the daily: 'Only one team in the world, from the American firm Geron, is pushing for clinical trials and that is a very well understood, specific application for spinal cord injury. And we have concerns with that. This doctor has not published a peer-reviewed paper. How can one independently verify the results?'

The report quoted Shroff as saying that patients from the US and Britain were going to her for treatment, and that her therapy appeared to con sist of injecting a clear liquid, containing millions of cells cultivated from a human egg, into a bicep or base of the spine. Shroff said her embryos were obtained with consent.

Researchers in Britain say stem cell therapies are a decade away. They add that in the West and advanced economies of Asia, there are legal constraints that keep scientists from rushing ahead with treatments before they have been 'thoroughly tested for safety and effectiveness'.

Alison Murdoch, of Newcastle University Fertility Centre, which made headlines in May by cloning embryos, told the newspaper: 'Desperate patients might be tempted, but false hope is not hope. There are all sorts of ethical issues that this kind of unregulated work throws up. There are no animal tests, no checks on where the embryos are coming from.'

The report said Shroff had defended her actions by saying that everything she did was within India's guidelines and that she had informed the authorities.

'Everything I have done has been notified to the Indian Council of Medical Research (ICMR) and there has been no comeback,' she told the newspaper.

The ICMR said it had been informed but had not given consent.

The report quoted Prasanna Hota, a top civil servant in India's health ministry, as saying: 'We have our concerns and worries about Dr Shroff's work.'

--IANS
'"/>




Related medicine news :

1. Designer baby for British couple
2. British Authorities Seize Spurious Drugs
3. Collaborations planned between British Organization and Indian health care industry
4. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
5. British Women Flies to India for Treatment of Breast Cancer
6. Sharp Increase In Morning-After Pill Sales Among British Women
7. British company developing ‘Safer Cigarettes
8. British man Recovered from HIV
9. British medical education suffers shortage of bodies
10. Relief For British MS Patients: Cannabis-Based Oral Spray
11. British Grandmother has timely bypass surgery in India
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... 29, 2016 , ... For those who skip meals occasionally (which is pretty ... among the many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya ... Water® radio show. Bonny and Lawrence noted that because proper nutrition, including water, provides ...
(Date:4/29/2016)... ... April 29, 2016 , ... Innovations with Ed Begley Jr., ... episode, airing third quarter 2016 via Discovery Channel. Dates and show times TBA. ... Products, located in Greenwood, Wisconsin applies product research and development and continuous technological ...
(Date:4/29/2016)... ... April 29, 2016 , ... CURE Media Group ... patients with cancer, today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci ... Extraordinary Healer® for Oncology Nursing , which honors nurses who have dedicated their ...
(Date:4/29/2016)... Rafael, CA (PRWEB) , ... April 29, 2016 , ... ... week long softball camp from July 24th – 27th for girls aged 10-18. All ... camp is held at the beautiful Clark V. Whited Complex, one of the finest ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... George Phillips und Stephen ...    ArisGlobal®, ein führender Anbieter ... gab heute bekannt, dass neue Führungskräfte zum ... gestoßen sind, die vielfältige Erfahrungen mitbringen.  Dies ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
Breaking Medicine Technology: